Naohisa Ogo Selected Research

3-tritylthio-L-alanine

4/2021	Design, synthesis, and evaluation of a novel prodrug, a S-trityl-l-cysteine derivative targeting kinesin spindle protein.
12/2010	S-trityl-L-cysteine derivative induces caspase-independent cell death in K562 human chronic myeloid leukemia cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naohisa Ogo Research Topics

Disease

16	Neoplasms (Cancer) 02/2022 - 03/2010
2	Glioblastoma (Glioblastoma Multiforme) 03/2016 - 07/2013
2	Lymphoma (Lymphomas) 05/2011 - 11/2010
1	Lung Neoplasms (Lung Cancer) 02/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022
1	Residual Neoplasm 02/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 01/2022
1	Heart Failure 02/2021
1	Fibrosis (Cirrhosis) 10/2020
1	Mouth Neoplasms (Oral Cancer) 05/2020
1	Caliciviridae Infections 04/2017
1	Glioma (Gliomas) 03/2016
1	Brain Neoplasms (Brain Tumor) 03/2016
1	Drug-Related Side Effects and Adverse Reactions 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2010
1	Hematologic Neoplasms (Hematological Malignancy) 12/2010

Drug/Important Bio-Agent (IBA)

5	STX-0119IBA 10/2020 - 11/2010
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022 - 01/2019
4	SurvivinIBA 05/2020 - 03/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2010
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
2	YHO-1701IBA 02/2022 - 05/2020
2	TOR Serine-Threonine KinasesIBA 01/2022 - 03/2016
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 03/2010
2	3-tritylthio-L-alanineIBA 04/2021 - 12/2010
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 01/2019
1	Anaplastic Lymphoma KinaseIBA 02/2022
1	alectinibIBA 02/2022
1	Tyrosine Kinase InhibitorsIBA 02/2022
1	RNA (Ribonucleic Acid)IBA 02/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Dynamin IIIBA 01/2022
1	AntigensIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	LipidsIBA 01/2022
1	ProdrugsIBA 04/2021
1	KinesinsIBA 04/2021
1	Amino Acids FDA Link 04/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	NSC 74859IBA 10/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	Antiviral Agents (Antivirals)IBA 04/2017
1	Indicators and Reagents (Reagents)IBA 04/2017
1	Disinfectants (Biocides)IBA 04/2017
1	Bendamustine Hydrochloride FDA Link 01/2017
1	Alkylating AgentsIBA 01/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2016
1	Fluvoxamine (Luvox)FDA LinkGeneric 03/2016
1	Epirubicin (Ellence)FDA LinkGeneric 01/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2016
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2014
1	GTP Phosphohydrolases (GTPases)IBA 01/2014
1	Dynamins (Dynamin)IBA 01/2014
1	BenzenesulfonamidesIBA 03/2012
1	Tryptophan (L-Tryptophan)FDA Link 03/2012
1	KynurenineIBA 03/2012
1	Cyclin D1IBA 05/2011
1	CaspasesIBA 12/2010
1	Oncogene Proteins (Oncogene Protein)IBA 11/2010

Therapy/Procedure

5	Therapeutics 01/2022 - 03/2012
1	Aftercare (After-Treatment) 02/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Immunotherapy 01/2022
1	Oral Administration 11/2010